C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2006
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/20/2006	CA2547186A1 Novel biochalcophenes and their prodrugs as antiprotozoal agents
11/16/2006	WO2006122072A2 Processes for preparing biaryl ureas and analogs thereof
11/16/2006	WO2006121922A1 Monoamine re-uptake inhibitors and methods relating thereto
11/16/2006	WO2006121097A1 Bicyclic heterocyclic derivative or salt thereof
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	WO2006120266A1 Novel antioxidants which are obtained from a natural and synthetic source and method of obtaining same
11/16/2006	WO2006120178A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes
11/16/2006	WO2006120125A1 Diacylglycerol acyltransferase inhibitors
11/16/2006	WO2006120104A1 Inhibitors of prolyl endopeptidase
11/16/2006	WO2006119745A2 Method for the production of olefins from carbonyl compounds
11/16/2006	WO2006076415A3 Exo- and diastereo- selective syntheses of himbacine analogs
11/16/2006	US20060258737 Resistance-repellent retroviral protease inhibitors
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	US20060258683 Para-sulfonyl substituted phenyl compounds as modulators of ppars
11/16/2006	US20060258666 c-fms kinase inhibitors
11/16/2006	US20060257987 Ppar modulators
11/16/2006	CA2835779A1 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
11/16/2006	CA2607121A1 Diacylglycerol acyltransferase inhibitors
11/16/2006	CA2606780A1 Processes for preparing biaryl ureas and analogs thereof
11/16/2006	CA2598365A1 Analogs of 4-hydroxyisoleucine and uses thereof
11/15/2006	EP1721522A2 Substituted phenylketo-enoles as biocides and herbicides
11/15/2006	EP1720814A2 Process for recovering organic compounds from aqueous streams containing same
11/15/2006	EP1416927B1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP1351907B1 2-butyl-3-(4- 3(dibutylamino)propoxy benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863766A Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient
11/15/2006	CN1863523A Application of L-NBP in preparation of medicine for preventing and curing celebralin farction
11/15/2006	CN1861621A Process of preparing burdock glucoside and glucosidgen thereof
11/15/2006	CN1861590A Flavoneoid derivative and its preparation process and use
11/15/2006	CN1861588A Internal ester monomer compound and application in preparing anti cancer medicine
11/15/2006	CN1861587A Internal ester monomer compound and application in preparing anti cancer medicine
11/15/2006	CN1284623C Method for the production of a catalyst containing vanadium, phosphorus, and oxygen
11/14/2006	US7136389 Method and system for a low-overhead mobility management protocol in the internet protocol layer
11/14/2006	US7135582 Transition metal complex having diphosphine compound as ligand
11/14/2006	US7135577 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom
11/14/2006	US7135574 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent
11/14/2006	US7135570 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	US7135479 Compounds which are both serotonin reuptake inhibitors and antagonists of the 5HT1A receptor
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	CA2171836C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006117696A2 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
11/09/2006	WO2006117611A1 Histamine h3-recept0r ligands and their therapeutic application
11/09/2006	WO2006116905A1 Medicinal compounds as antagonists of the platelet- activating factor receptor
11/09/2006	WO2006116872A1 Methods for hormone profiling
11/09/2006	WO2006028963A3 Substituted heterocyclic compounds and uses thereof
11/09/2006	US20060252945 Process for the asymmetric hydrogenation of beta-amino ketones
11/09/2006	US20060252825 Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	CA2606269A1 Histamine h3-recept0r ligands and their therapeutic application
11/09/2006	CA2598491A1 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
11/08/2006	EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006	EP1719746A1 Optical resolver, process for producing optically active isomer, and 1,5-substituted bicyclo (3.3.0) -2-oxaoctane compound
11/08/2006	EP1718612A1 Novel benzofurans and indols
11/08/2006	EP1718292A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation disorders
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1047687B2 Process for the production of gamma-butyrolactone
11/08/2006	CN1858044A Method for producing furol by plant stalk pelletizing
11/08/2006	CN1858043A Method for producing furol by extruding plant stalk
11/08/2006	CN1858042A Synthetic process for 2-butyl-3(hydroxy 3,5-diiodo-benzoyl) benzofuran
11/08/2006	CN1857771A High selectivity catalyst for preparing tetrahydrofuran and its preparing process
11/08/2006	CN1857403A Process of extracting total salvianolic acid and total salvianolic acid extract
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/07/2006	US7132569 N,N-disubstituted-2,7-dialkyl-8-aryl-4-octeneamides and the intermediates: N,N-disubstituted-5-halo- or azido-2-alkyl-4-pentenamides and 2-alkyl-5-(4-aryl-2-halo- or azido-3-alkylbutylbutyrolactones that may be used to prepare them
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132455 Phthalamide derivatives
11/07/2006	US7132449 useful for the therapeutic treatment of Trypanosoma cruzi infection
11/07/2006	US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006	US7132420 Aspartic protease inhibitors
11/07/2006	US7132215 Ester compounds, polymers, resist compositions and patterning process
11/07/2006	US7132001 Oxidative dye couplers; light, wash and rub fastness; storage stability; intense shades
11/07/2006	CA2200578C N-substituted piperidinyl bicyclic benzoate derivatives
11/07/2006	CA2132132C Process for the preparation of 3-arylbenzofuranones
11/02/2006	WO2006116218A1 Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
11/02/2006	WO2006116151A1 Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
11/02/2006	WO2006116150A1 Dihydrobenzofuran derivatives and uses thereof
11/02/2006	WO2006116136A1 Dihydrobenzofuran derivatives and uses thereof
11/02/2006	WO2006115134A1 Novel benzofuran derivative, pharmaceutical composition comprising the same, and use of the derivative or composition
11/02/2006	WO2006115112A1 Polymerizable liquid crystal compound, polymerizable liquid crystal composition comprising the same, and polymer produced using them
11/02/2006	WO2006114371A1 Novel compounds for treating inflammatory diseases
11/02/2006	WO2006114272A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS
11/02/2006	WO2006114264A1 Acetylene derivatives
11/02/2006	WO2006114262A1 Acetylene derivatives
11/02/2006	WO2006061392A3 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
11/02/2006	WO2006061215A3 2-alkyl-cycloalk(en)yl-carboxamides
11/02/2006	WO2005041899A3 Orally available sphingosine 1-phosphate receptor agonists and antagonists
11/02/2006	US20060247451 Crystalline base of citalopram
11/02/2006	US20060247450 Exo- and diastereo- selective syntheses of himbacine analogs
11/02/2006	US20060247447 Novel phosphorus addition process for improvement of catalysts suitable for maleic anhydride production
11/02/2006	US20060247446 Inert nonporous support such as steatite; used for gas-phase partial oxidation of aromatic hydrocarbons for preparing aldehydes, carboxylic acids and/or carboxylic anhydrides
11/02/2006	US20060247307 imino compound as antiinflammatory agent, anticarcinogenic agent for treating chronic inflammation and cancers; activating peroxisome proliferator-activated receptor
11/02/2006	US20060247283 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060246377 Suitable as photolatent acids in ArF resist technology; thermally stable, even at high bake temperatures during processing and provide high photospeed; surface coatings, printing inks, printing plates, dental formulations, colour filters, resists, or image-recording materials, photoresist
11/02/2006	EP1717233A1 Histamine H3-receptor ligands and their therapeutic application

1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 472